Charcot-Marie-Tooth disease 1A (CMT1A) is the most common autosomal dominant demyelinating sensorimotor polyneuropathy. A few patients with Charcot-Marie-Tooth disease were reported in the literature to have epilepsy. We report on an African-American boy with CMT1A, with duplication of peripheral myelin protein 22 gene, who also developed intractable generalized tonic-clonic seizures and audiovisual hallucinations.
KleinCJDyckPJ. Genetic testing in inherited peripheral neuropathies. J Peripher Nerv Syst2005; 10: 77–84.
2.
SzigetiKGarciaCALupskiJR. Charcot-Marie-Tooth disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management. Genet Med2006; 8: 86–92.
3.
HauserWANelsonKB. Epidemiology of epilepsy in children. Cleve Clin J Med1989; 56(suppl 2): S185–194.
4.
PiantinoJATorresA. Myoclonic seizures in a patient with Charcot-Marie-Tooth disease. Pediatr Neurol2007; 36: 118–120.
5.
RoutsonisKGeorgiadisG. Peroneal muscular atrophy and epilepsy with cerebellar ataxia and choreoathetosis in the same family. J Neurol Sci1984; 64: 161–173.
6.
SmithNJEspirMLMatthewsWB. Familial myoclonic epilepsy with ataxia and neuropathy with additional features of Friedreich's ataxia and peroneal muscular atrophy. Brain1978; 101: 461–472.
7.
PanasMKaradimaGKalfakisNFloroskufiPVassilopoulosD. Charcot-Marie-Tooth disease type 1A with central nervous system involvement in two generations. J Neurol2004; 251: 484–485.
8.
FrassonEPoloADi SummaA. Multiple sclerosis associated with duplicated CMT1A: a report of two cases. J Neurol Neurosurg Psychiatry1997; 63: 413–414.
9.
ParmantierEBraunCThomasJLPeyronFMartinezSZalcB. PMP-22 expression in the central nervous system of the embryonic mouse defines potential transverse segments and longitudinal columns. J Comp Neurol1997; 378: 159–172.
